NCT02551900

Brief Summary

Warm water based cycling exercise training would more favorable than cold water based cycling exercise training and land based cycling exercise in vascular function in type 2 diabetic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 15, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 16, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2016

Completed
Last Updated

April 4, 2018

Status Verified

April 1, 2018

Enrollment Period

1 year

First QC Date

September 15, 2015

Last Update Submit

April 3, 2018

Conditions

Keywords

Type 2 DiabetesVascular FunctionWater ExerciseWarm WaterCold Water

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in glycemic control

    The glycemic control will be quantified using blood samples. Fasting blood glucose, HbA1c, insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and C-reactive protein will be measured with standard procedures at the clinical laboratory (N health Lab, Samitivej, Sriracha, Thailand). Homeostasis model assessment (HOMA-IR will be calculated by using equation of \[Fasting glucose (mg/dL) × Insulin level (uU/mL) / 405\].

    Baseline, 12 weeks

  • Change from baseline in vascular reactivity

    Vascular reactivity or brachial and popliteal artery flow-mediated dilatation (FMD) will be assessed with the ultrasound equipment (CX50, Philips, USA), using the blood occlusion technique on the right forearm and lower leg. The brachial artery and the popliteal artery will be imaged above the antecubital fossa in the longitudinal plane and proximal slightly above the popliteal fossa. Brachial FMD will be measured at baseline and the cuff placed around the right forearm will be inflated to 50 mmHg above systolic blood pressure for 5 minutes and then deflated for 5 minutes of recovery. While popliteal FMD will be measured at baseline and the cuff will be positioned on the lower right leg below the knee will be inflated to 250 mmHg for 5 minutes and then deflated for 5 minutes of recovery. FMD will be calculated from the formula FMD= (D2-D1)x100/D1 when D1 is the brachial or popliteal artery diameter at baseline, D2 is the maximal post-occlusion brachial or popliteal artery diameter.

    Baseline, 12 weeks

  • Change from baseline in cutaneous blood flow

    Cutaneous blood flow will be determined by laser Doppler Flowmetry (DRT4, Moore Instrument, UK). Laser Doppler Flowmetry probes will be attached to the dorsum of middle fingertip and the dorsum of the foot. The occlusion cuffs will be placed around left middle upper arm and calf were inflated to a pressure of 50 mmHg above the systolic pressure and will be remained inflated for 3 minutes, after which it will be rapidly released, producing a brief high-flow state resulting in artery dilation due to increase shear stress. The peak Laser Doppler Flux (peak LDF) and after 5 min occlusion period will be recorded.

    Baseline, 12 weeks

Secondary Outcomes (8)

  • Change from baseline in physical fitness

    Baseline, 12 weeks

  • Change from baseline in physical fitness

    Baseline, 12 weeks

  • Change from baseline in physical fitness

    Baseline, 12 weeks

  • Change from baseline in physical fitness

    Baseline, 12 weeks

  • Change from baseline in blood chemistry

    Baseline, 12 weeks

  • +3 more secondary outcomes

Study Arms (2)

Warm water exercise & Cold water exercise

EXPERIMENTAL
Other: Warm water exerciseOther: Cold water exercise

Warm water exercise & Land cycling exercise

ACTIVE COMPARATOR
Other: Warm water exerciseOther: Land based cycling exercise

Interventions

Warm water based cycling exercise training program will be based on cycling in warm water (temperature 34◦C ). Warm water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.

Warm water exercise & Cold water exerciseWarm water exercise & Land cycling exercise

Cold water based cycling exercise training will be based on cycling in cold water (temperature 20◦C ). Cold water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.

Warm water exercise & Cold water exercise

Land based cycling exercise training will be based on ride a bicycle ergometer (Monark 894e, Sweden). Land based cycling exercise training will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.

Warm water exercise & Land cycling exercise

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Participants were excluded if they dropped out or completed less than 80% of the training schedule.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laemchabang stadium, Sukhumvit Rd

Si Racha, Changwat Chon Buri, 20230, Thailand

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Daroonwan Suksom, Ph.D.

    Faculty of Sport Science Chulalongkorn University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Faculty of Sport Science

Study Record Dates

First Submitted

September 15, 2015

First Posted

September 16, 2015

Study Start

September 1, 2014

Primary Completion

September 15, 2015

Study Completion

December 15, 2016

Last Updated

April 4, 2018

Record last verified: 2018-04

Locations